These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35792338)

  • 1. Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping review.
    Prang KH; Karanatsios B; Verbunt E; Wong HL; Yeung J; Kelaher M; Gibbs P
    Contemp Clin Trials; 2022 Aug; 119():106843. PubMed ID: 35792338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registry-based randomised controlled trials: conduct, advantages and challenges-a systematic review.
    Shiely F; O Shea N; Murphy E; Eustace J
    Trials; 2024 Jun; 25(1):375. PubMed ID: 38863017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paper II: thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registries.
    Krause KR; Tay J; Douglas WA; Sammy A; Baba A; Goren K; Thombs BD; Howie AH; Oskoui M; Frøbert O; Trakadis Y; Little J; Potter BK; Butcher NJ; Offringa M
    J Clin Epidemiol; 2023 Jul; 159():330-343. PubMed ID: 37146660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining key design elements of registry-based randomised controlled trials: a scoping review.
    Karanatsios B; Prang KH; Verbunt E; Yeung JM; Kelaher M; Gibbs P
    Trials; 2020 Jun; 21(1):552. PubMed ID: 32571382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians.
    Prang KH; Karanatsios B; Zhang A; Verbunt E; Wong HL; Wong V; Gately L; Tran B; Gibbs P; Kelaher M
    Trials; 2023 Feb; 24(1):92. PubMed ID: 36747274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry randomised trials: a methodological perspective.
    Doherty DA; Tong SYC; Reilly J; Shrapnel J; McDonald S; Ahern S; Harris I; Tam CS; Brennan AL; Hodgson C; Wilcox L; Balagurunathan A; Butcher BE; Reid CM
    BMJ Open; 2023 Mar; 13(3):e068057. PubMed ID: 36858472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paper I: Heterogeneous use of registry data for participant identification and primary outcome ascertainment is found in registry-based randomized controlled trials: A scoping review.
    Baba A; Tay J; Sammy A; Douglas WA; Goren K; Krause KR; Howie AH; Little J; Oskoui M; Taljaard M; Thombs BD; Potter BK; Butcher NJ; Offringa M
    J Clin Epidemiol; 2023 Jul; 159():289-299. PubMed ID: 37146658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No differences were found between effect estimates from conventional and registry-based randomized controlled trials.
    Mathes T; Klaßen P; Pieper D
    J Clin Epidemiol; 2019 Jan; 105():80-91. PubMed ID: 30257186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials.
    Mathes T; Buehn S; Prengel P; Pieper D
    J Clin Epidemiol; 2018 Jan; 93():120-127. PubMed ID: 28951111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and barriers for the use of Australian cancer registries as platforms for randomized clinical trials.
    Yan MK; Adler NR; Heriot N; Shang C; Zalcberg JR; Evans S; Wolfe R; Mar VJ
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):344-352. PubMed ID: 34811922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classifying, measuring and improving the quality of data in trauma registries: A review of the literature.
    O'Reilly GM; Gabbe B; Moore L; Cameron PA
    Injury; 2016 Mar; 47(3):559-67. PubMed ID: 26830127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current state of rare disease registries and databases in Australia: a scoping review.
    Ruseckaite R; Mudunna C; Caruso M; Helwani F; Millis N; Lacaze P; Ahern S
    Orphanet J Rare Dis; 2023 Jul; 18(1):216. PubMed ID: 37501152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data Quality in Rare Diseases Registries.
    Kodra Y; Posada de la Paz M; Coi A; Santoro M; Bianchi F; Ahmed F; Rubinstein YR; Weinbach J; Taruscio D
    Adv Exp Med Biol; 2017; 1031():149-164. PubMed ID: 29214570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Completeness, Comparability, Validity, and Timeliness in Cancer Registries: A Scoping Review.
    Shokrizadeharani L; Batooli Z; Heydarian S; Sharif R; Ghaderkhany S; Tamehbidgoli M; Ataiejahanbegloo F; Hieber D; Kuhn P
    Stud Health Technol Inform; 2023 Jun; 305():160-163. PubMed ID: 37386985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data.
    Fitzpatrick T; Perrier L; Tricco AC; Straus SE; Jüni P; Zwarenstein M; Lix LM; Smith M; Rosella LC; Henry DA
    BMJ Open; 2017 Feb; 7(2):e013770. PubMed ID: 28213601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hernia registries: the CORE project.
    Kyle-Leinhase I; Köckerling F; Jørgensen LN; Montgomery A; Gillion JF; Rodriguez JAP; Hope W; Muysoms F
    Hernia; 2018 Aug; 22(4):561-575. PubMed ID: 29307057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?
    Eriksson JW; Eliasson B; Bennet L; Sundström J
    Diabetologia; 2022 Oct; 65(10):1575-1586. PubMed ID: 35902386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative.
    Mikita JS; Mitchel J; Gatto NM; Laschinger J; Tcheng JE; Zeitler EP; Swern AS; Flick ED; Dowd C; Lystig T; Calvert SB
    Ther Innov Regul Sci; 2021 Jan; 55(1):6-18. PubMed ID: 32572772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operational Characteristics of Central Cancer Registries that Support the Generation of High-Quality Surveillance Data.
    Edwards P; Bernacet A; Tangka FKL; Pordell P; Beizer J; Wilson R; Blumenthal W; Jones SF; Cole-Beebe M; Subramanian S
    J Registry Manag; 2022; 49(1):10-16. PubMed ID: 36968178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.